Analysis of drug resistance spectrum and its mechanism in 1017 clinical bacterial isolates

Abstract

Abstract: Objective To investigate the drug susceptibility of the clinical bacterial isolates to provide evidence for more adequate use of antibiotics. Methods Altogether 1017 clinical bacterial isolates were identified by BD Phoenix and tested for resistance against antimicrobial agents by K-B method. WHONET5 was applied for the analysis. Results The most frequent bacteria detected included P. aeruginosa (19.37%), coagulase-negative Staphylococci (CNS, 17.70%), E. coli (13.27%), S. aureu (SA, 12.09%), E. faecalis (11.8%), and K. pneumoniae (7.57%). In gram-negative isolates, the susceptibility rate of imipenem was 81.5%, and that of ceftazidime was above 70%. The incidences of E.coli and K. pneumoniae isolates producing extended spectrum beta-lactamase (ESBLs) were 34.8% and 45.5% respectively. In gram-positive isolates, the susceptibility rates of vancomycin and Teicoplanin were 98.8% and 100.0% respectively, and those of furazolidone, imipenem, amikacin, piperacillin/ tazobactam were above 70%. The oxacillin resistant rates of CNS and SA were 78.2% and 46.8%. Conclusion The 1017 clinical bacterial isolates are characterized by high ratio of ESBL production and oxacillin resistance, suggesting the importance of adequate use of antimicrobial agents and effective control measures for reducing the drug resistance and preventing the spread of multi drug-resistant bacteria.

CLC Number:

R978.81

GENG Sui-na, RUI Yong-yu, WANG Qian, MOU Cheng-hui, ZHOU Xiao-hong, ZHANG Jie. Analysis of drug resistance spectrum and its mechanism in 1017 clinical bacterial isolates[J]. Journal of Southern Medical University, 2005, 25(12): 1529-1532,1545.

References

[1] 叶应妩,王毓三.全国临床检验操作规程[M].第2版,南京:东南大学出版社,1997.472-531.
[2] National Committee for Clinical Laboratory Standards.Performance standards for antimicrobiol susceptibility testing [M].12th informsuppl.M2-A7 and M7-A5.Wayne Pennsylvania:NCCLS,2002.34-80.
[3] 马越,李景云,张新妹,等.2002年临床常见细菌耐药性监测[J].中华检验医学杂志,2004,27(1):38-45.Ma Y,Li JY,Zhang XM,et al.Antimicrobial resistance of clinical bacteria in national surveillance network in 2002 [J].Chin J Lab Med,2004,27(1):38-45.
[4] 张亚莉,史占军,李中齐,等.大肠埃希菌、肺炎克雷伯菌产超广谱β-内酰胺酶菌株的耐药性监测[J].中华医院感染学杂志,2004,14(3):331-3.Zhang YL,Shi ZJ,Li ZQ,et al.ESBLs-producing Escherichia coli and Klebsiella pneumoniae:an antibiotic-resistance analysis [J].Chin J Nosocomiol,2004,14(3):331-3.
[5] 龙军,吕苏成.下呼吸道感染患者产超广谱β-内酰胺酶的细菌的耐药性分析[J].第一军医大学学报,2004,24(4):439-44.Long J,Lu SC.Drug-resistance analysis of Gram-negative bacilli producing extended-spectrum β-lactamases in lower respiratory tract infection [J].J First Mil Med Univ/Di Yi Ju Yi Da Xue Xue Bao,2004,24(4):439-44.
[6] 崔伟历,徐德兴,李文玲,等.大肠埃希菌所致泌尿生殖系感染的细菌耐药分析[J].第一军医大学学报,2004,24(8):940-5.Cui WL,Xu DX,Li WL,et al.Analysis of anti-microbial resistance ofEscherichia coli that caused infection in urogenital system [J].J First Mil Med Univ/Di Yi Ju Yi Da Xue Xue Bao,2004,24 (8):940-5.
[7] 张亚莉,汪能平,赖福才,等.葡萄球菌属对常用抗生素耐药情况调查[J].第一军医大学学报,2004,23(1):82-4.Zhang YL,Wang NP,Lai FC,et al.Survey on drug resistance of Staphylococcus to commonly used antibiotics [J].J First Mil Med Univ/Di Yi Ju Yi Da Xue Xue Bao,2004,23(1):82-4.